- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07682909
oneKNEE - Prospective, Non-interventional, Multicenter PMCF-Study (oneKNEE)
oneKNEE - Prospective, Non-interventional, Multicenter Post-Market Clinical Follow-Up Study
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Safety and Clinical Performance will be observed:
Safety: All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure.
Clinical Performance: Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Heike Oberascher
- Telefonnummer: +49 7461 95
- E-Mail: studies@aesculap.de
Studieren Sie die Kontaktsicherung
- Name: Stefan Maenz, Dr.
- Telefonnummer: +49 7461 95
- E-Mail: studies@aesculap.de
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Patient age ≤ 80 years
- Indication for a total knee replacement with one of the variants
- Written informed consent
- Willingness and mental ability to participate at the long-term follow-up examinations
Exclusion Criteria:
- Contraindications acc. to the Instructions for Use (IFU)
- Patient age < 18 years
- Known pregnancy
- BMI > 40
- Secondary gonarthrosis (e.g. rheumatoid arthritis, post-traumatic)
- Patients classified as high risk (ASA class >3)
- Patients with immunodeficiency, i.e. patients currently receiving immunosuppressive therapy or patients with severe immunodeficiency requiring drug therapy
- Preoperative: aHKA > 190° or aHKA < 170°
- Preoperative: aHKA > 190° or aHKA < 170°[KB1.1][HO1.2][KB1.3][HO1.4]
- Patients held in a custodial setting und - Patients in a relationship of dependence on the sponsor, the clinic or the investigator
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Safety of the implant
Zeitfenster: 2 years after implantation
|
Safety in terms of clinical outcome of oneKNEE® All adverse device effects: serious and non-serious adverse events with relation to either the product or the surgical procedure.
|
2 years after implantation
|
|
Clinical Performance in terms of clinical outcome of oneKNEE®
Zeitfenster: 2 years after implantation
|
Clinical Performance in terms of clinical outcome of oneKNEE®. Difference in Oxford Knee Score (OKS) 2 years after implantation compared to preoperative state. The Oxford Knee Score (OKS) is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA. It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA. It is short, reproducible, valid and sensitive to clinically important changes over time. OKS ranges from 0 to 48 with 48 being the best outcome. |
2 years after implantation
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Intraoperative complications
Zeitfenster: day of surgery
|
day of surgery
|
|
|
Optional: OrthoPilot® Data
Zeitfenster: Day of surgery
|
During surgery all data measured and stored by OrthoPilot® the computer assistant (e.g.
time needed for the surgery, alignment of all implant components) will be evaluated.
|
Day of surgery
|
|
Clinical Outcome by evaluating the Oxford Knee Score
Zeitfenster: V4=3 months post OP, V5= 1year p.OP, V6= 2years p.OP, V7= 5years p.OP
|
The Oxford Knee Score, OKS is a validated joint-specific patient-reported outcome measure that is commonly employed to assess the outcome of TKA.
It is a 12-item, patient-reported questionnaire originally developed and validated specifically to assess function and pain in patients undergoing TKA.
It is short, reproducible, valid and sensitive to clinically important changes over time.
OKS ranges from 0 to 48 with 48 being the best outcome.
|
V4=3 months post OP, V5= 1year p.OP, V6= 2years p.OP, V7= 5years p.OP
|
|
Evaluation of Changes in Quality of Life
Zeitfenster: V1= pre OP, V3= Discharge, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
The EQ-5D-5L is a standardized instrument used to measure health outcomes. Developed by the EuroQol Group (EQ), it assesses five dimensions (5D) of health: Mobility Self-care Usual activities Pain/discomfort Anxiety/depression Each dimension has five levels (5L) of severity: no problems, slight problems, moderate problems, severe problems, and extreme problems |
V1= pre OP, V3= Discharge, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
|
Evaluation of Patient Satisfaction by using PROMS: FJS
Zeitfenster: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
Forgotten Joint Score (FJS) : A joint-specific questionnaire with the aim to measure PRO of joint disorders . FJS is designed to measure the ability of the patient to "forget" about their problematic joint after treatment. Scale:
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee functional outcome
Zeitfenster: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
Range of Motion (ROM)
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee alignment, measurement of LDFA: Lateral distal femoral angle
Zeitfenster: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
LDFA: Lateral distal femoral angle.
The angle between the mechanical axis of the femur and the knee joint line.
Normal values typically range between 85° and 90° Medial proximal tibial angle (MPTA) and lateral distal femoral angle.
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee alignment, measurement of MPTA: Medial proximal tibial angle
Zeitfenster: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
MPTA: Medial proximal tibial angle.
The angle between the mechanical axis of the tibia and the knee joint line.
Normal values also typically average around 87° ± 3°.
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Knee alignment, measurement of HKA: Hip Knee Angle
Zeitfenster: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
HKA: (Hip Knee Angle).
The mechanical angle between the center of the femoral head, the center of the knee, and the center of the ankle.
It represents the overall lower limb alignment (e.g., neutral, varus, or valgus)
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Radiologically relevant findings by using AI
Zeitfenster: V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
"Image biopsy lab" is a Digital AI platform that supports physicians and healthcare professionals in transforming medical imaging data into diagnostic findings.
|
V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP
|
|
Adverse events
Zeitfenster: until end of study, up to 5 years.
|
Serious and non-serious adverse events (SAE/AE)
|
until end of study, up to 5 years.
|
|
Device deficiencies assessed by Adverse Events
Zeitfenster: until end of study, up to 5 years
|
In any case of Adverse Events marked as "related to the product/device"
|
until end of study, up to 5 years
|
|
Survival of implant components
Zeitfenster: From V3=Discharge to V7= 5 years post OP
|
From V3=Discharge to V7= 5 years post OP
|
|
|
Anterior knee pain
Zeitfenster: V1= preoperatively, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
Anterior knee pain is used to evaluate the performance of the implantation and the implant itself. Rating is classified according to the description of Waters and Bentley in four dimensions: 0 (no pain), I (Mild pain that does not intrude on daily activities), II (Moderate pain that is a nuisance; patient not considering further surgery), III (Severe pain; Patient considering further surgery). The scoring is according to Feller et al. 0, 5, 10 and 15 points, respectively. (Feller et al., J Bone Joint Surg Am. 2003 Feb;85(2):212-7). |
V1= preoperatively, V4= 3 months post OP, V5= 1 year post OP, V6= 2 years post OP, V7= 5 years post OP,
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Anne Postler, PD Dr. med, Städt. Klinikum Dresden
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- AAG-O-H-25103
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .